Collection

Vivaldi study: results

Results for the Vivaldi study for antibody and cellular immune responses to coronavirus (COVID-19) in approximately 340 care homes.

• From: UK Health Security Agency
• Published: 28 May 2021
• Last updated: 27 January 2023 — See all updates

All the reports for the Vivaldi study can be found on this page.

Reports

• Vivaldi 3: Boosters strongly enhance SARS-CoV-2 antibody and cellular responses in elderly residents in care homes
  • 23 December 2021
  • Independent report
• Vivaldi 3: coronavirus (COVID-19) antibody and cellular immune response in care homes study report
  • 10 December 2021
  • Independent report
• Vivaldi 2: coronavirus (COVID-19) new variant (B.1.1.7) in care homes study report
  • 7 May 2021
  • Independent report
• Vivaldi 2: coronavirus (COVID-19) reinfections in care homes study report
  • 6 May 2021
  • Independent report
• Vivaldi 2: coronavirus (COVID-19) vaccines in care homes study report
  • 7 May 2021
  • Independent report
• Vivaldi 1: coronavirus (COVID-19) care homes study report
  • 3 July 2020
  • Independent report

Privacy notice

• Vivaldi study: privacy notice
  • 27 January 2023
  • Guidance

Published 28 May 2021
Last updated 27 January 2023 + show all updates

1. 27 January 2023

   Added Privacy notice.

2. 23 December 2021

   Added Vivaldi 3: Boosters strongly enhance SARS-CoV-2 antibody and cellular responses in elderly residents in care homes.

3. 10 December 2021

   Added Vivaldi 3: coronavirus (COVID-19) antibody and cellular immune response in care homes study report.

4. 28 May 2021

   First published.